{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T01:01:07Z","timestamp":1768266067547,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T00:00:00Z","timestamp":1617408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T00:00:00Z","timestamp":1617408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s11064-021-03310-4","type":"journal-article","created":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T06:02:26Z","timestamp":1617429746000},"page":"1717-1724","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Effects of the Calcium Channel Blocker Otilonium Bromide on Seizure Activity in Rats With Pentylenetetrazole-Induced Convulsions"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2488-2012","authenticated-orcid":false,"given":"Arife","family":"Erdogan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mumin Alper","family":"Erdogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozum","family":"Atasoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oytun","family":"Erbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,3]]},"reference":[{"key":"3310_CR1","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/S0140-6736(14)60456-6","volume":"385","author":"SL Mosh\u00e9","year":"2015","unstructured":"Mosh\u00e9 SL, Perucca E, Ryvlin P et al (2015) (2015) Epilepsy: new advances. Lancet Lond Engl 385:884\u2013898","journal-title":"Lancet Lond Engl"},{"key":"3310_CR2","first-page":"265","volume-title":"Epilepsy","author":"CA Kernich","year":"2003","unstructured":"Kernich CA (2003) Epilepsy. Lippincott Wil-liams & Wilkins, Philapedia, pp 265\u20136"},{"issue":"365","key":"3310_CR3","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1056\/NEJMra1004418","volume":"2011","author":"P Kwan","year":"2011","unstructured":"Kwan P, Schachter SC, Brodie MJ (2011) Drug-Resistant epilepsy. N Engl J Med 2011(365):919\u2013926","journal-title":"N Engl J Med"},{"issue":"6","key":"3310_CR4","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","volume":"51","author":"P Kwan","year":"2010","unstructured":"Kwan P, Arzimanoglou A, Berg AT et al (2010) (2010) Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 51(6):1069\u20131077","journal-title":"Epilepsia"},{"issue":"19","key":"3310_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0733-8619(05)70005-0","volume":"2001","author":"SC Schachater","year":"2001","unstructured":"Schachater SC (2001) Epilepsy. Neurol Clin 2001(19):57\u201378","journal-title":"Neurol Clin"},{"key":"3310_CR6","unstructured":"Epilepsy. World Health Organization Available at: http:\/\/www.who.int\/news-room\/factsheets\/detail\/epilepsy. (Accessed: 10th August 2018)."},{"issue":"6","key":"3310_CR7","doi-asserted-by":"publisher","first-page":"663","DOI":"10.2174\/0929867320666131119152201","volume":"21","author":"G Curia","year":"2014","unstructured":"Curia G, Lucchi C, Vinet J et al (2014) Pathophysiogenesis of mesial temporal lobe epilepsy: is prevention of damage antiepileptogenic? Curr Med Chem 21(6):663\u2013688","journal-title":"Curr Med Chem"},{"key":"3310_CR8","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S1474-4422(04)00906-8","volume":"3","author":"CE Elger","year":"2004","unstructured":"Elger CE, Helmstaedter C, Kurthen M (2004) Chronic epilepsy and cognition. Lancet Neurol. 3:663\u2013672","journal-title":"Lancet Neurol."},{"key":"3310_CR9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0074-7742(08)60611-X","volume":"42","author":"I Mody","year":"1998","unstructured":"Mody I (1998) Ion channels in epilepsy. Int. Rev. Neurobiol. 42:199\u2013226","journal-title":"Int. Rev. Neurobiol."},{"issue":"Suppl 1","key":"3310_CR10","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/j.seizure.2004.04.016","volume":"13","author":"IE Leppik","year":"2004","unstructured":"Leppik IE (2004) Zonisamide: chemistry, mechanism of action, and pharmacokinetics. Seizure 13(Suppl 1):S5-9","journal-title":"Seizure"},{"key":"3310_CR11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.4161\/chan.4.6.14106","volume":"4","author":"SM Cain","year":"2010","unstructured":"Cain SM (2010) Snutch TP (2010) Contributions of T-type calcium channel isoforms to neuronal firing. Channels 4:44\u201351","journal-title":"Channels"},{"issue":"3561\u20133568","key":"3310_CR12","first-page":"2004","volume":"10","author":"S Evangelista","year":"2004","unstructured":"Evangelista S (2004) Quaternary ammonium derivatives as spasmolytics for irritable bowel syndrome. Curr Pharm Des 10(3561\u20133568):2004","journal-title":"Curr Pharm Des"},{"key":"3310_CR13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1365-2982.2004.00517.x","volume":"16","author":"PR Strege","year":"2004","unstructured":"Strege PR, Evangelista S, Lyford GL et al (2004) (2004) Otilonium bromide inhibits calcium entry through L-type calcium channels in human intestinal smooth muscle. Neurogastroenterol Motil 16:167\u2013173","journal-title":"Neurogastroenterol Motil"},{"key":"3310_CR14","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00437.2009","author":"PR Strege","year":"2010","unstructured":"Strege PR, Sha L, Beyder A et al (2010) T-type Ca2+ channel modulation by otilonium bromide. Am J Physiol Gastrointest Liver Physiol. https:\/\/doi.org\/10.1152\/ajpgi.00437.2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"3310_CR15","doi-asserted-by":"publisher","DOI":"10.1179\/1743132814Y.0000000391","author":"O Erbas","year":"2015","unstructured":"Erbas O, Solmaz V, Aksoy D (2015) Inhibitor effect of dexketoprofen in rat model of pentylenetetrazol-induced seizures. Neurol Res. https:\/\/doi.org\/10.1179\/1743132814Y.0000000391","journal-title":"Neurol Res"},{"key":"3310_CR16","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0024-3205(00)00638-X","volume":"67","author":"C Demougeot","year":"2000","unstructured":"Demougeot C, Marie C (2000) Beley A (2000) Importance of iron location in iron-induced hydroxyl radical production by brain slices. Life Sci 67:399\u2013410","journal-title":"Life Sci"},{"key":"3310_CR17","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1054\/ceca.2001.0205","volume":"29","author":"JC Boyer","year":"2001","unstructured":"Boyer JC, Magous R, Christen MO et al (2001) (2001) Contraction of human colonic circular smooth muscle cells is inhibited by the calcium channel blocker pinaverium bromide. Cell Calcium 29:429\u2013438","journal-title":"Cell Calcium"},{"key":"3310_CR18","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1023\/B:JOBB.0000008024.77488.48","volume":"35","author":"AM Yunker","year":"2003","unstructured":"Yunker AM (2003) McEnery MW (2003) Low-voltage-activated (\u201cT-Type\u201d) calcium channels in review. J Bioenerg Biomembr 35:533\u2013575","journal-title":"J Bioenerg Biomembr"},{"issue":"3","key":"3310_CR19","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0301-0082(02)00077-1","volume":"68","author":"M Avoli","year":"2002","unstructured":"Avoli M, D\u2019Antuono M, Louvel J et al (2002) Network and pharmacological mechanisms leading to epileptiform synchronization in the limbic system in vitro. Prog Neurobiol 68(3):167\u2013207","journal-title":"Prog Neurobiol"},{"key":"3310_CR20","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S1474-4422(10)70059-4","volume":"9","author":"M Mantegazza","year":"2010","unstructured":"Mantegazza M, Curia G, Biagini G et al (2010) Voltage- gated sodium channels as therapeutic targets in epilepsy and other neurological disorders. Lancet Neurol 9:413\u2013424","journal-title":"Lancet Neurol"},{"key":"3310_CR21","first-page":"61","volume":"2005","author":"TP Snutch","year":"2005","unstructured":"Snutch TP, Peloquin J, Mathews E et al (2005) Molecular Properties of Voltage-Gated Calcium Channels, Voltage-Gated Calcium Channels. Springer, Landes Biosciences 2005:61\u201394","journal-title":"Springer, Landes Biosciences"},{"key":"3310_CR22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1152\/physrev.00018.2002","volume":"83","author":"E Perez-Reyes","year":"2003","unstructured":"Perez-Reyes E (2003) (2003) Molecular physiology of low-voltage-activated T-type calcium channels. Physiol Rev 83:117\u2013161 (PubMed PMID: 12506128)","journal-title":"Physiol Rev"},{"key":"3310_CR23","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.neuron.2008.08.019","volume":"59","author":"E Neher","year":"2008","unstructured":"Neher E (2008) Sakaba T (2008) Multiple roles of calcium ions in the regulation of neurotransmitter release. Neuron 59:861\u2013872 (PubMed PMID: 18817727)","journal-title":"Neuron"},{"issue":"Suppl 6","key":"3310_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.0013-9580.2004.455003.x","volume":"45","author":"E Ben-Menachem","year":"2004","unstructured":"Ben-Menachem E (2004) Pregabalin pharmacology and its relevance to clinical practice. Epilepsia 45(Suppl 6):13\u201318","journal-title":"Epilepsia"},{"issue":"4","key":"3310_CR25","doi-asserted-by":"publisher","first-page":"403","DOI":"10.4149\/gpb_2011_04_403","volume":"30","author":"L Lacinova","year":"2011","unstructured":"Lacinova L (2011) T-type calcium channel blockers\u2014new and notable. Gen Physiol Biophys 30(4):403\u2013409","journal-title":"Gen Physiol Biophys"},{"issue":"2","key":"3310_CR26","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/WNF.0b013e318170577f","volume":"32","author":"PE Bermejo","year":"2009","unstructured":"Bermejo PE, Dorado R (2009) Zonisamide for migraine prophylaxis in patients refractory to topiramate. Clin Neuropharmacol 32(2):103\u2013106","journal-title":"Clin Neuropharmacol"},{"issue":"4","key":"3310_CR27","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.numecd.2005.05.003","volume":"15","author":"D Del Rio","year":"2005","unstructured":"Del Rio D, Stewart AJ (2005) A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis 15(4):316\u2013328","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"3","key":"3310_CR28","first-page":"211","volume":"36","author":"EU Iwuozo","year":"2019","unstructured":"Iwuozo EU, Obiako OR, Ejiofor JI, Kehinde JA, Abubakar SA (2019) Effect of Epilepsy and Antiepileptic Drugs Therapy on Erythrocyte Malondialdehyde and Some Antioxidants in Persons with Epilepsy. West Afr J Med. 36(3):211","journal-title":"West Afr J Med."},{"issue":"10","key":"3310_CR29","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.seizure.2012.09.003","volume":"21","author":"B Menon","year":"2012","unstructured":"Menon B, Ramalingam K (2012) Kumar RV (2012) Oxidative stress in patients with epilepsy is independent of antiepileptic drugs. Seizure 21(10):780\u2013784","journal-title":"Seizure"},{"key":"3310_CR30","doi-asserted-by":"publisher","first-page":"795259","DOI":"10.1155\/2012\/795259","volume":"2012","author":"CC Aguiar","year":"2012","unstructured":"Aguiar CC, Almeida AB, Araujo PV et al (2012) (2012) Oxidative stress and epilepsy: literature review. Oxid Med Cell Longevity 2012:795259","journal-title":"Oxid Med Cell Longevity"},{"issue":"4","key":"3310_CR31","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00424-014-1454-x","volume":"466","author":"BJ Kopecky","year":"2014","unstructured":"Kopecky BJ, Liang R, Bao J (2014) T-type calcium channel blockers as neuroprotective agents. Pfl\u00fcgers Archiv-European Journal of Physiology 466(4):757\u2013765","journal-title":"Pfl\u00fcgers Archiv-European Journal of Physiology"},{"key":"3310_CR32","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ejphar.2017.02.015","volume":"799","author":"J Khamseekaew","year":"2017","unstructured":"Khamseekaew J, Kumfu S, Wongjaikam S et al (2017) Effects of iron overload, an iron chelator and a T-Type calcium channel blocker on cardiac mitochondrial biogenesis and mitochondrial dynamics in thalassemic mice. Eur J Pharmacol 799:118\u2013127","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"3310_CR33","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10571-012-9886-3","volume":"33","author":"VA Y\u00fcrekli","year":"2013","unstructured":"Y\u00fcrekli VA, G\u00fcrler S, Naz\u0131ro\u011flu M, U\u011fuz AC, Koyuncuo\u011flu HR (2013) Zonisamide attenuates MPP (+)-induced oxidative toxicity through modulation of Ca 2+ signaling and caspase-3 activity in neuronal PC12 cells. Cell Mol Neurobiol 33(2):205\u2013212","journal-title":"Cell Mol Neurobiol"},{"key":"3310_CR34","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1007\/PL00005370","volume":"359","author":"P Santicioli","year":"1999","unstructured":"Santicioli P, Zagorodnyuk V, Renzetti AR, Maggi CA (1999) Antimuscarinic, calcium channel blocker and tachykinin NK2 receptor antagonist actions of otilonium bromide in the circular muscle of guinea-pig colon. Naunyn Schmiedebergs Arch Pharmacol 359:420\u2013427","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"5","key":"3310_CR35","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1046\/j.1471-4159.2001.00633.x","volume":"79","author":"M Saffroy","year":"2001","unstructured":"Saffroy M, Torrens Y, Glowinski J, Beaujouan JC (2001) Presence of NK2 binding sites in the rat brain. J Neurochem 79(5):985\u2013996","journal-title":"J Neurochem"},{"key":"3310_CR36","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0306-4522(90)90315-U","volume":"34","author":"G Sperk","year":"1990","unstructured":"Sperk G, Marksteiner J, Saria A, Humpel C (1990) Differential changes in tachykinins after kainic acid-induced seizures in the rat. Neuroscience 34:219\u2013224","journal-title":"Neuroscience"},{"key":"3310_CR37","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/j.1460-9568.1996.tb01221.x","volume":"8","author":"V Bucinskaite","year":"1996","unstructured":"Bucinskaite V, Theodorsson E, Crumpton K, Stenfors C, Ekblom A, Lundeberg T (1996) Effects of repeated sensory stimulation (electro-acupuncture) and physical exercise (running) on open-field behaviour and concentrations of neuropeptides in the hippocampus in WKY and SHR rats. Eur J Neurosci 8:382\u2013387","journal-title":"Eur J Neurosci"},{"key":"3310_CR38","first-page":"60","volume":"15","author":"AA Mathe","year":"1999","unstructured":"Mathe AA (1999) Neuropeptides and electroconvulsive treatment. J Ect 15:60\u201375","journal-title":"J Ect"},{"key":"3310_CR39","doi-asserted-by":"publisher","first-page":"5286","DOI":"10.1073\/pnas.96.9.5286","volume":"96","author":"H Liu","year":"1999","unstructured":"Liu H, Mazarati AM, Katsumori H, Sankar R, Wasterlain CG (1999) Substance P is expressed in hippocampal principal neurons during status epilepticus and plays a critical role in the maintenance of status epilepticus. Proc Natl Acad Sci USA 96:5286\u20135291","journal-title":"Proc Natl Acad Sci USA"},{"key":"3310_CR40","doi-asserted-by":"publisher","first-page":"12096","DOI":"10.1073\/pnas.96.21.12096","volume":"96","author":"H Liu","year":"1999","unstructured":"Liu H, Cao Y, Basbaum AI, Mazarati AM, Sankar R, Wasterlain CG (1999) Resistance to excitotoxin-induced seizures and neuronal death in mice lacking the preprotachykinin A gene. Proc Natl Acad Sci USA 96:12096\u201312101","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-021-03310-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-021-03310-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-021-03310-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T21:10:39Z","timestamp":1623186639000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-021-03310-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,3]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["3310"],"URL":"https:\/\/doi.org\/10.1007\/s11064-021-03310-4","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,3]]},"assertion":[{"value":"10 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The experimental procedures employed in the present study were approved by the Animal Ethics Committee of Demiroglu Science University (Approval no. 2920122).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}